Brief: Enliven Therapeutics Inc Files For Mixed Shelf Of Up To $400 Mln – SEC Filing
23/06/2023 22:31
June 23 (Reuters) - Enliven Therapeutics Inc ELVN.O :
* ENLIVEN THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO
$400
MILLION – SEC FILING
Source: (https://shorturl.at/dqAH8)
Further company coverage: ELVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses